Absence of PAF Actions Increases Angiogenesis

Overview

Journal Br J Pharmacol

Publisher Wiley

Specialty Pharmacology

Date 2004 Mar 17

PMID 15023858

Authors

Marina Ziche

Affiliations

Soon will be listed here.

References

Kohno T, Mizukami H, Suzuki M, Saga Y, Takei Y, Shimpo M . Interleukin-10-mediated inhibition of angiogenesis and tumor growth in mice bearing VEGF-producing ovarian cancer. Cancer Res. 2003; 63(16):5091-4. View

Wei L, Kuo M, Chen C, Chou C, Lai K, Lee C . Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway. Oncogene. 2003; 22(10):1517-27. DOI: 10.1038/sj.onc.1206226. View

Cozzolino F, Torcia M, Aldinucci D, Ziche M, Almerigogna F, Bani D . Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci U S A. 1990; 87(17):6487-91. PMC: 54561. DOI: 10.1073/pnas.87.17.6487. View

Griffioen A, Damen C, Blijham G, Groenewegen G . Tumor angiogenesis is accompanied by a decreased inflammatory response of tumor-associated endothelium. Blood. 1996; 88(2):667-73. View

Brizzi M, Battaglia E, Montrucchio G, Dentelli P, Del Sorbo L, Garbarino G . Thrombopoietin stimulates endothelial cell motility and neoangiogenesis by a platelet-activating factor-dependent mechanism. Circ Res. 1999; 84(7):785-96. DOI: 10.1161/01.res.84.7.785. View

Goede V, Brogelli L, Ziche M, Augustin H . Induction of inflammatory angiogenesis by monocyte chemoattractant protein-1. Int J Cancer. 1999; 82(5):765-70. DOI: 10.1002/(sici)1097-0215(19990827)82:5<765::aid-ijc23>3.0.co;2-f. View

Bar D, Apte R, Voronov E, Dinarello C, Cohen S . A continuous delivery system of IL-1 receptor antagonist reduces angiogenesis and inhibits tumor development. FASEB J. 2003; 18(1):161-3. DOI: 10.1096/fj.03-0483fje. View

Montrucchio G, Lupia E, Battaglia E, Del Sorbo L, Boccellino M, Biancone L . Platelet-activating factor enhances vascular endothelial growth factor-induced endothelial cell motility and neoangiogenesis in a murine matrigel model. Arterioscler Thromb Vasc Biol. 2000; 20(1):80-8. DOI: 10.1161/01.atv.20.1.80. View

Cervenak L, Morbidelli L, Donati D, Donnini S, Kambayashi T, Wilson J . Abolished angiogenicity and tumorigenicity of Burkitt lymphoma by interleukin-10. Blood. 2000; 96(7):2568-73. View

10.

Szekanecz Z, Koch A . Chemokines and angiogenesis. Curr Opin Rheumatol. 2001; 13(3):202-8. DOI: 10.1097/00002281-200105000-00009. View

11.

Hatzi E, Murphy C, Zoephel A, Rasmussen H, Morbidelli L, Ahorn H . N-myc oncogene overexpression down-regulates IL-6; evidence that IL-6 inhibits angiogenesis and suppresses neuroblastoma tumor growth. Oncogene. 2002; 21(22):3552-61. DOI: 10.1038/sj.onc.1205440. View

12.

Deo D, Axelrad T, Robert E, Marcheselli V, Bazan N, Hunt J . Phosphorylation of STAT-3 in response to basic fibroblast growth factor occurs through a mechanism involving platelet-activating factor, JAK-2, and Src in human umbilical vein endothelial cells. Evidence for a dual kinase mechanism. J Biol Chem. 2002; 277(24):21237-45. DOI: 10.1074/jbc.M110955200. View

13.

Offersen B, Knap M, Marcussen N, Horsman M, Hamilton-Dutoit S, Overgaard J . Intense inflammation in bladder carcinoma is associated with angiogenesis and indicates good prognosis. Br J Cancer. 2002; 87(12):1422-30. PMC: 2376289. DOI: 10.1038/sj.bjc.6600615. View

14.

Auerbach R, Lewis R, Shinners B, Kubai L, Akhtar N . Angiogenesis assays: a critical overview. Clin Chem. 2003; 49(1):32-40. DOI: 10.1373/49.1.32. View